Skip to content
Get alerts
GovInfoNow
Unrated Drug recall · FDA · Published May 18, 2026

AbbVie Recalls PRED MILD Eye Drops Due to Stability Issues

AbbVie recalls 2,736 bottles of PRED MILD prednisolone acetate ophthalmic suspension due to failed stability specifications. Check your lot numbers.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0551-2026DrugAbbVie ›
Take action

Contact the company

Recalling firmAbbVie Inc.1 N Waukegan Rd · North Chicago, IL 60064-1802
✎ GovInfoNow plain-language explainer

AbbVie Inc. is recalling PRED MILD, a prednisolone acetate ophthalmic suspension, because the product failed stability specifications. The recall affects 2,736 bottles distributed nationwide in the U.S. The specific health risks or remedy actions are not detailed in this record. Read more at govinfonow.com/recall/31301-abbvie-recalls-pred-mild-eye-drops-due-to-stability-issues.

Source Summary by GovInfoNow · govinfonow.com/recall/31301-abbvie-recalls-pred-mild-eye-drops-due-to-stability-issues · Updated October 9, 2026 · FDA enforcement record: FDA #D-0551-2026

Cite this page

“AbbVie Recalls PRED MILD Eye Drops Due to Stability Issues.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/31301-abbvie-recalls-pred-mild-eye-drops-due-to-stability-issues. Based on FDA recall #D-0551-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0551-2026%22&limit=1).

The FDA announced on May 18, 2026, that AbbVie Inc. is recalling PRED MILD eye drops due to failed stability specifications. The recall affects 2,736 bottles distributed nationwide.

How to tell if you have it

  • Brand: AbbVie
  • Product: PRED MILD Eye Drops (prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL)
  • NDC: 11980-174-10
  • Lot codes: 402805, 407596
  • Expiration date: 08/2026
  • Quantity: 2,736 bottles

The hazard

The product failed stability specifications. The FDA classified this as a Class III recall.

Context

GovInfoNow's records show AbbVie Inc. has had 9 other recalls since August 1, 2013. Other recent recalls of similar products include the Similasan Eye Drops recall on April 23, 2026, and the Lupin prednisolone acetate ophthalmic suspension recall on June 4, 2026.

How to tell if you have this one

Look for PRED MILD prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL bottles manufactured by Allergen, Inc., an AbbVie company. Check for NDC 11980-174-10 and lot numbers 402805 or 407596 with an expiration date of 08/2026.

  • Brand
    AbbVie
  • Category
    Drug

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “US Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 16 days after the firm started it.

1. Firm started the recall: May 18, 202612. FDA classified it Class III: May 27, 202623. Published in FDA’s Enforcement Report: Jun 3, 202632026
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Apotex Recalls Paroxetine 37.5mg Due to Dissolution Failure
Apotex Corp.Ajanta Pharma Recalls Ranolazine 1000mg Due to Dissolution Failure
Ajanta Pharma USA IncClear Eyes Eye Drops Recall: Lack of Sterility Risk
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare companyAmneal Estradiol Gel Recall: Defective Empty or Partial Packets
Amneal Pharmaceuticals, LLCInventia Chlorthalidone Recall: Failed Dissolution Specs
Inventia Healthcare Limited

Latest drug recalls

SV Labs Toronto Corporation recalls Benzoyl Peroxide Wash, USP, 10%, packaged in a)5 FL OZ (148mL) bottles (NDC 0536-1261-63), and b) 8.5 FL OZ (237 mL)
SV Labs · September 1, 2026SUN PHARMA /TARO recalls Lidocaine Ointment USP, 5%, Speermint Flavor, 50 g Jar, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario,
SUN PHARMA /TARO · August 31, 2026Supernus Pharmaceuticals, Inc. recalls Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma
Supernus Pharmaceuticals · August 31, 2026Amneal Pharmaceuticals of New York, LLC recalls Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use
Amneal · August 28, 2026Macleods Pharmaceuticals Limited recalls Olanzapine Tablets, USP 5 mg, 30-count bottle, Rx Only, Manufactured For: Macleods Pharma USA, Inc. Princeton, NJ,
Macleods · August 27, 2026Ajanta Pharma USA Inc recalls Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles, Rx Only, Marketed by: Ajanta Pharma USA Inc.,
Ajanta Pharma · August 25, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0551-2026 (May 18, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0551-2026 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA